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Introduction: Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by 
thromboembolic events, adverse pregnancy outcomes, and the presence of antiphospholipid 
antibodies. Management of these patients can be complicated by recurrent events and difficulties 
with monitoring therapy. Consequently, many of these patients are referred to specialized 
Thrombosis Centers for management. 
Methods: A web-based data registry was implemented at the 8 Thrombophilia Pilot Centers in 
August 2003. Information collected includes demographics, referral patterns, and medical history, 
diagnostic laboratory and radiographic data. 
Results: Of 2983 unique patients enrolled in the Registry as of October 2006, 285 (9.6%) were 
referred for APS. Most were female (n=205; 72%) and Caucasian (n=234; 82%). Twenty-seven were 
pediatric (9.5%). The primary referral sources for APS patients were Hematology/Oncology (n=68; 
24%), Internal Medicine (n=40; 14%), and Family Medicine (n=38; 13.3%). Clinical manifestations 
included venous thromboembolism (deep venous thrombosis: n=158; 55.4%; pulmonary emboli: 
n=82; 28.8%), arterial thromboembolism (stroke: n=50; 17.5%), and adverse pregnancy outcomes 
(n=47 of 205; 23%). Sixty-six patients (30%) had a concurrent autoimmune disorder. Fifty-one 
women (25%) were referred for pre-pregnancy counseling or pregnancy management. Venous 
thromboembolism in unusual locations was not uncommon (intraabdominal: n=11 (3.9%); cerebral 
sinus: n=9 (3.2%); inferior vena cava: n=8; (2.8%); intraocular: n=8; (2.8%)). A positive family 
history was reported by 52 patients, with thrombosis (n=29; 56%) and stroke (n=13; 25%) being the 
most common manifestations reported in family members. Most patients were subsequently followed 
through the Thrombosis Center (n=214; 75%). 
Conclusions: Patients with APS are frequently referred to specialized Thrombosis Centers for 
evaluation and management of their disease. Almost 10% are pediatric, and a family history of 
thrombosis is frequently present. 
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